BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 12948260)

  • 1. Angiotensin converting enzyme inhibitor induced cough: experience in Siriraj Hospital.
    Buranakitjaroen P; Sriussadaporn S; Phoojaroenchanachai M; Sangprasert P; Saravich S
    J Med Assoc Thai; 2003 Jul; 86(7):647-54. PubMed ID: 12948260
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [A prospective study on the cough mechanism induced by angiotensin-converting enzyme inhibitors in patients with hypertension].
    Ye RJ; He QY; Gai J; Shang Y
    Zhonghua Jie He He Hu Xi Za Zhi; 2004 Sep; 27(9):581-4. PubMed ID: 15498266
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angiotensin converting enzyme inhibitors and cough--a north Indian study.
    Singh NP; Uppal M; Anuradha S; Agarwal A; Rizvi SN
    J Assoc Physicians India; 1998 May; 46(5):448-51. PubMed ID: 11273288
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High prevalence of persistent cough with angiotensin converting enzyme inhibitors in Chinese.
    Woo KS; Nicholls MG
    Br J Clin Pharmacol; 1995 Aug; 40(2):141-4. PubMed ID: 8562296
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dechallenge and rechallenge method showed different incidences of cough among four ACE-Is.
    Tumanan-Mendoza BA; Dans AL; Villacin LL; Mendoza VL; Rellama-Black S; Bartolome M; Ragual J; Flor B; Valdez J
    J Clin Epidemiol; 2007 Jun; 60(6):547-53. PubMed ID: 17493508
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Noscapine suppresses angiotensin converting enzyme inhibitors-induced cough.
    Mooraki A; Jenabi A; Jabbari M; Zolfaghari MI; Javanmardi SZ; Mahmoudian M; Bastani B
    Nephrology (Carlton); 2005 Aug; 10(4):348-50. PubMed ID: 16109080
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of ACE inhibition versus non-ACE inhibitor antihypertensive treatment on myocardial fibrosis in patients with arterial hypertension. Retrospective analysis of 120 patients with left ventricular endomyocardial biopsies.
    Brilla CG; Rupp H; Maisch B
    Herz; 2003 Dec; 28(8):744-53. PubMed ID: 14689110
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety and efficacy of angiotensin-converting enzyme inhibitors in symptomatic severe aortic stenosis: Symptomatic Cardiac Obstruction-Pilot Study of Enalapril in Aortic Stenosis (SCOPE-AS).
    Chockalingam A; Venkatesan S; Subramaniam T; Jagannathan V; Elangovan S; Alagesan R; Gnanavelu G; Dorairajan S; Krishna BP; Chockalingam V;
    Am Heart J; 2004 Apr; 147(4):E19. PubMed ID: 15077102
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of genetic factors associated with susceptibility to angiotensin-converting enzyme inhibitors-induced cough.
    Grilo A; Sáez-Rosas MP; Santos-Morano J; Sánchez E; Moreno-Rey C; Real LM; Ramírez-Lorca R; Sáez ME
    Pharmacogenet Genomics; 2011 Jan; 21(1):10-7. PubMed ID: 21052031
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angiotensin converting enzyme inhibitors and the allergist.
    O'Hollaren MT; Porter GA
    Ann Allergy; 1990 Jun; 64(6):503-6. PubMed ID: 2189318
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Late onset angiotensin-converting enzyme induced angioedema: case report and review of the literature.
    Guo X; Dick L
    J Okla State Med Assoc; 1999 Feb; 92(2):71-3. PubMed ID: 10024785
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angiotensin-converting enzyme inhibitor or angiotensin II type 1 receptor antagonist therapy is associated with prolonged patient and graft survival after renal transplantation.
    Heinze G; Mitterbauer C; Regele H; Kramar R; Winkelmayer WC; Curhan GC; Oberbauer R
    J Am Soc Nephrol; 2006 Mar; 17(3):889-99. PubMed ID: 16481415
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Underutilization of angiotensin converting enzyme inhibitors among heart failure patients.
    Lean QY; Shamsuddin N; Wan Ahmad WA
    Med J Malaysia; 2008 Aug; 63(3):216-21. PubMed ID: 19248693
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiotensin converting enzyme inhibitor-induced angioedema more prevalent in transplant patients.
    Abbosh J; Anderson JA; Levine AB; Kupin WL
    Ann Allergy Asthma Immunol; 1999 May; 82(5):473-6. PubMed ID: 10353579
    [TBL] [Abstract][Full Text] [Related]  

  • 15. No impact of hyperkalaemia with renin-angiotensin system blockades in maintenance haemodialysis patients.
    Han SW; Won YW; Yi JH; Kim HJ
    Nephrol Dial Transplant; 2007 Apr; 22(4):1150-5. PubMed ID: 17255126
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Different patterns of angioedema in patients with and without angiotensin-converting enzyme inhibitor therapy.
    Herkner H; Temmel AF; Müllner M; Havel C; Hirschl MM; Kofler J; Laggner AN
    Wien Klin Wochenschr; 2001 Mar; 113(5-6):167-71. PubMed ID: 11293945
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.
    Prescrire Int; 2005 Oct; 14(79):180-6. PubMed ID: 16285075
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiotensin converting enzyme inhibitors and cough.
    Town GI; Hallwright GP; Maling TJ; O'Donnell TV
    N Z Med J; 1987 Mar; 100(820):161-3. PubMed ID: 2837699
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacogenetic predictors of angiotensin-converting enzyme inhibitor-induced cough: the role of ACE, ABO, and BDKRB2 genes.
    Mas S; Gassò P; Alvarez S; Ortiz J; Sotoca JM; Francino A; Carne X; Lafuente A
    Pharmacogenet Genomics; 2011 Sep; 21(9):531-8. PubMed ID: 21832968
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Angiotensin-converting enzyme inhibitors after renal transplantation.
    Bravo P; Felgueiras J; Santos C; Oliveira C; Ponce P
    Transplant Proc; 2008 Apr; 40(3):740-2. PubMed ID: 18455003
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.